287 related articles for article (PubMed ID: 25505447)
1. Disruption of O-GlcNAc Cycling in C. elegans Perturbs Nucleotide Sugar Pools and Complex Glycans.
Ghosh SK; Bond MR; Love DC; Ashwell GG; Krause MW; Hanover JA
Front Endocrinol (Lausanne); 2014; 5():197. PubMed ID: 25505447
[TBL] [Abstract][Full Text] [Related]
2. Caenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauer.
Forsythe ME; Love DC; Lazarus BD; Kim EJ; Prinz WA; Ashwell G; Krause MW; Hanover JA
Proc Natl Acad Sci U S A; 2006 Aug; 103(32):11952-7. PubMed ID: 16882729
[TBL] [Abstract][Full Text] [Related]
3. Enzymatic assay for UDP-GlcNAc and its application in the parallel assessment of substrate availability and protein O-GlcNAcylation.
Sunden M; Upadhyay D; Banerjee R; Sipari N; Fellman V; Kallijärvi J; Purhonen J
Cell Rep Methods; 2023 Jul; 3(7):100518. PubMed ID: 37533645
[TBL] [Abstract][Full Text] [Related]
4. A little sugar goes a long way: the cell biology of O-GlcNAc.
Bond MR; Hanover JA
J Cell Biol; 2015 Mar; 208(7):869-80. PubMed ID: 25825515
[TBL] [Abstract][Full Text] [Related]
5. Real Talk: The Inter-play Between the mTOR, AMPK, and Hexosamine Biosynthetic Pathways in Cell Signaling.
Cork GK; Thompson J; Slawson C
Front Endocrinol (Lausanne); 2018; 9():522. PubMed ID: 30237786
[TBL] [Abstract][Full Text] [Related]
6. O-GlcNAcylation and O-GlcNAc Cycling Regulate Gene Transcription: Emerging Roles in Cancer.
Parker MP; Peterson KR; Slawson C
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33916244
[TBL] [Abstract][Full Text] [Related]
7. Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation.
Lucena MC; Carvalho-Cruz P; Donadio JL; Oliveira IA; de Queiroz RM; Marinho-Carvalho MM; Sola-Penna M; de Paula IF; Gondim KC; McComb ME; Costello CE; Whelan SA; Todeschini AR; Dias WB
J Biol Chem; 2016 Jun; 291(25):12917-29. PubMed ID: 27129262
[TBL] [Abstract][Full Text] [Related]
8. Hexosamine biosynthetic pathway and
Kim DY; Park J; Han IO
Am J Physiol Cell Physiol; 2023 Oct; 325(4):C981-C998. PubMed ID: 37602414
[TBL] [Abstract][Full Text] [Related]
9. Hexosamines, insulin resistance, and the complications of diabetes: current status.
Buse MG
Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E1-E8. PubMed ID: 16339923
[TBL] [Abstract][Full Text] [Related]
10. O-GlcNAcase Expression is Sensitive to Changes in O-GlcNAc Homeostasis.
Zhang Z; Tan EP; VandenHull NJ; Peterson KR; Slawson C
Front Endocrinol (Lausanne); 2014; 5():206. PubMed ID: 25520704
[TBL] [Abstract][Full Text] [Related]
11. A Caenorhabditis elegans model of insulin resistance: altered macronutrient storage and dauer formation in an OGT-1 knockout.
Hanover JA; Forsythe ME; Hennessey PT; Brodigan TM; Love DC; Ashwell G; Krause M
Proc Natl Acad Sci U S A; 2005 Aug; 102(32):11266-71. PubMed ID: 16051707
[TBL] [Abstract][Full Text] [Related]
12. Silencing the Nucleocytoplasmic O-GlcNAc Transferase Reduces Proliferation, Adhesion, and Migration of Cancer and Fetal Human Colon Cell Lines.
Steenackers A; Olivier-Van Stichelen S; Baldini SF; Dehennaut V; Toillon RA; Le Bourhis X; El Yazidi-Belkoura I; Lefebvre T
Front Endocrinol (Lausanne); 2016; 7():46. PubMed ID: 27252680
[TBL] [Abstract][Full Text] [Related]
13. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
[TBL] [Abstract][Full Text] [Related]
14. O-GlcNAc in cancer: An Oncometabolism-fueled vicious cycle.
Hanover JA; Chen W; Bond MR
J Bioenerg Biomembr; 2018 Jun; 50(3):155-173. PubMed ID: 29594839
[TBL] [Abstract][Full Text] [Related]
15. Role of O-linked N-acetylglucosamine (O-GlcNAc) modification of proteins in diabetic cardiovascular complications.
Chatham JC; Young ME; Zhang J
Curr Opin Pharmacol; 2021 Apr; 57():1-12. PubMed ID: 32937226
[TBL] [Abstract][Full Text] [Related]
16. The Many Ways by Which
Biwi J; Biot C; Guerardel Y; Vercoutter-Edouart AS; Lefebvre T
Molecules; 2018 Nov; 23(11):. PubMed ID: 30400201
[TBL] [Abstract][Full Text] [Related]
17. Repeated sleep deprivation decreases the flux into hexosamine biosynthetic pathway/O-GlcNAc cycling and aggravates Alzheimer's disease neuropathology in adult zebrafish.
Park J; Kim DY; Hwang GS; Han IO
J Neuroinflammation; 2023 Nov; 20(1):257. PubMed ID: 37946213
[TBL] [Abstract][Full Text] [Related]
18. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.
Vosseller K; Wells L; Lane MD; Hart GW
Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5313-8. PubMed ID: 11959983
[TBL] [Abstract][Full Text] [Related]
19. Nutrient-Driven
Krause MW; Love DC; Ghosh SK; Wang P; Yun S; Fukushige T; Hanover JA
Front Endocrinol (Lausanne); 2018; 9():521. PubMed ID: 30250452
[TBL] [Abstract][Full Text] [Related]
20. Too sweet to resist: Control of immune cell function by O-GlcNAcylation.
de Jesus T; Shukla S; Ramakrishnan P
Cell Immunol; 2018 Nov; 333():85-92. PubMed ID: 29887419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]